Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): A randomised multicentre, open-label, phase 2 trial

1. Gianni, L.
2. Pienkowski, T.
3. Im, Y.-H.
4. Roman, L.
5. Tseng, L.-M.
6. Liu, M.-C.
7. Lluch, A.
8. Staroslawska, E.
9. de la Haba-Rodriguez, J.
10. Im, S.-A.
11. Pedrini, J.L.
12. Poirier, B.
13. Morandi, P.
14. Semiglazov, V.
15. Srimuninnimit, V.
16. Bianchi, G.
17. Szado, T.
18. Ratnayake, J.
19. Ross, G.
20. Valagussa, P.